Implementation of good clinical practice guidelines in vaccine trials in developing countries
- 12 April 2007
- Vol. 25 (15) , 2852-2857
- https://doi.org/10.1016/j.vaccine.2006.09.079
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A multi‐country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and designTropical Medicine & International Health, 2005
- Policymakers’ views regarding the introduction of new-generation vaccines against typhoid fever, shigellosis and cholera in AsiaVaccine, 2004
- Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trialThe Lancet, 2004
- Foundations for a Phase III Human Immunodeficiency Virus Vaccine Trial: A Decade of Thai-U.S. Army Collaborative ResearchPublished by Oxford University Press (OUP) ,2004
- The future of rotavirus vaccines: a major setback leads to new opportunitiesThe Lancet, 2004
- Global reduction of Hib disease: what are the next steps? Proceedings of the meetingThe Journal of Pediatrics, 2003
- A new look at international research ethicsBMJ, 2000
- The future of research into rotavirus vaccineBMJ, 2000
- An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West AfricaSocial Science & Medicine, 1998